◆ 会议时间：2026年9月23-26日
◆ 会议地点：瑞典 斯德哥尔摩
◆ 会议简介：
2026年第26届WPA世界精神病学大会(WCP2026)将于2026年9月23-26日在瑞典斯德哥尔摩举行，会议由世界精神病学协会(WPA)组织。大会旨在汇集全球科学专家，一起研究与讨论精神病学和精神卫生领域的所有关键问题，促进和推动有关精神病学的科学知识，介绍最新的研究成果，促进和加强全球的科学合作。预计有来自世界各地的3000余名代表出席会议。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。
世界精神病学协会（WPA）成立于1950年，是一个旨在增加精神卫生领域工作所需知识和技能以照料精神病患者的全球性精神病学专业组织；WPA目前拥有来自125个国家的145个团体成员，代表着全球25万名精神病学家/医师。凭借72个科学部门，旨在传播信息并宣促进精神病学特定领域的协作工作。WPA制定了精神病实践的道德准则，包括“马德里宣言”（1996年），以及有关精神病实践相关主题和精神病医生角色的立场声明。WPA与其成员合作主办一年一度的WPA世界精神病学大会以及区域和专题会议，吸引全球精神卫生领导者并为共享经验和合作提供平台。WPA的官方期刊World Psychiatry在精神病学期刊排名第一，社会科学引文索引排名第一。
WCP 2026 - 26th WPA World Congress of Psychiatry
Date:
September 23-26, 2026
Location:
Stockholm, Sweden
Organized by:
World Psychiatric Association (WPA)
Theme: The Role of Psychiatry in the Changing World
摘要征文投稿：
Abstract deadline: 23 March 2026
点此提交摘要>>>Submit Abstract>>>
Please read the submission rules before submitting an abstract.
- Abstracts must be submitted online via the website only.
ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
- Presentation Type: Abstracts may be submitted for free communications or e-poster presentation.
The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
- Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
- Limitations:
- The same person may submit up to 4 abstracts regardless of presenting author.
- The same person may serve as presenting author on up to 4 abstracts.
- Presenting authors must be registered participants.
- Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications.
- The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
- Previously Presented/Published Policy:
- Abstracts must be original and must not have been published or presented at any other prior meeting. If, however, the abstract to be presented is on a topic you have used before, but now have developed a new poster or presentation with a varied viewpoint (or focused on a different aspect of the research) then you are welcome to submit the abstract.
- Abstracts must be submitted in English.
- Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
- Instructions for preparation of presentations will be made available on the congress website.
Guidelines for submission
Before you begin, please prepare the following information:
- Presenting author’s contact details:
-Full first and family name(s)
– Email address
– Affiliation details: department, institution / hospital, city, state (if relevant), country
– Phone number
- Author and co-authors’ details
- Preferred Presentation type: Free Communications or E-Poster
- Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
- Abstract text – limited to 250 words including acknowledgements. Please note: word count is affected when tables are included.
- Abstract topic– select the abstract topic per the list of topics.
- Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format.
- Abstracts should clearly state:
Background and aims
Methods
Results
Conclusions
- Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
- Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
- Submissions may not contain patient names, hospital ID numbers or other identifying information.
- The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
- Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
- You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
- Please contact us if you have not received confirmation that your abstract has been submitted.
- Please do not submit multiple copies of the same abstract.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
